Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 6, 2009, Pages 910-918

  Veit Haibach, Patrick ^a,c   Vogt, Florian M ^a   Jablonka, Robert ^a   Kuehl, Hilmar ^a   Bockisch, Andreas ^a   Beyer, Thomas ^a   Dahmen, Gerlinde ^b   Rosenbaum, Sandra ^a   Antoch, Gerald ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Ce PET CT; Cutaneous melanoma; Diagnostic accuracy; Follow up; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOBITRIDOL; IODINATED CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; DRUG UPTAKE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67349115175     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-1049-x     Document Type: Article

References (30)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 1 43 46
2. CM Balch SJ Soong JE Gershenwald JF Thompson DS Reintgen N Cascinelli 2001 Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 16 3622 3634
3. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Annals of surgery Nov 1970;172 5:902-8.
4. CM Balch AC Buzaid SJ Soong MB Atkins N Cascinelli DG Coit 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 16 3635 3648
5. CL Day Jr AJ Sober RA Lew MC Mihm Jr TB Fitzpatrick AW Kopf 1981 Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes Cancer 47 5 955 962
6. National Comprehensive Cancer Network. Fort Washington, PA. http://www.nccn.org .
7. H Tsao MB Atkins AJ Sober 2004 Management of cutaneous melanoma N Engl J Med 351 10 998 1012
8. KP Friedman RL Wahl 2004 Clinical use of positron emission tomography in the management of cutaneous melanoma Semin Nucl Med 34 4 242 253
9. SS Gambhir J Czernin J Schwimmer DH Silverman RE Coleman ME Phelps 2001 A tabulated summary of the FDG PET literature J Nucl Med 42 5 Suppl 1S 93S
10. MJ Reinhardt AY Joe U Jaeger A Huber A Matthies J Bucerius 2006 Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients J Clin Oncol 24 7 1178 1187
11. K Strobel R Dummer DB Husarik M Perez Lago TF Hany HC Steinert 2007 High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases Radiology 244 2 566 574
12. K Strobel J Skalsky HC Steinert R Dummer TF Hany U Bhure 2007 S-100B and FDG-PET/CT in therapy response assessment of melanoma patients Dermatology 215 3 192 201
13. G Antoch LS Freudenberg J Stattaus W Jentzen SP Mueller JF Debatin 2002 Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials AJR Am J Roentgenol 179 6 1555 1560
14. T Beyer G Antoch T Blodgett LF Freudenberg T Akhurst S Mueller 2003 Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology Eur J Nucl Med Mol Imaging 30 4 588 596
15. D Delbeke WH Martin MP Sandler WC Chapman JK Wright Jr CW Pinson 1998 Evaluation of benign vs malignant hepatic lesions with positron emission tomography Arch Surg 133 5 510 515
16. Valk PE, Bailey DL, Townsend DW, Maisey MN. Positron emission tomography: basic science and clinical practice. Berlin: Springer; 2003.
17. American Joint Committee on Cancer. Cancer staging manual. 6th edition. Heidelberg: Springer; 2002.
18. European Society for Medical Oncology. Viganello-Lugano, Switzerland. http://www.esmo.org .
19. T Tango 1998 Equivalence test and confidence interval for the difference in proportions for the paired-sample design Stat Med 17 8 891 908
20. D Fuster S Chiang G Johnson LM Schuchter H Zhuang A Alavi 2004 Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma? J Nucl Med 45 8 1323 1327
21. F Crippa M Leutner F Belli F Gallino M Greco S Pilotti 2000 Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma J Nucl Med 41 9 1491 1494
22. D Rinne RP Baum G Hor R Kaufmann 1998 Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients Cancer 82 9 1664 1671
23. JD Wagner DS Schauwecker D Davidson S Wenck SH Jung G Hutchins 2001 FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume J Surg Oncol 77 4 237 242
24. DS Tyler M Onaitis A Kherani A Hata E Nicholson M Keogan 2000 Positron emission tomography scanning in malignant melanoma Cancer 89 5 1019 1025
25. JD Wagner D Schauwecker D Davidson T Logan JJ Coleman JJ 3rd G Hutchins 2005 Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma Cancer 104 3 570 579
26. H Schoder SM Larson HW Yeung 2004 PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies J Nucl Med 45 Suppl 1 72S 81S
27. T Belhocine G Pierard M De Labrassinne T Lahaye P Rigo 2002 Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection Oncologist 7 4 271 278
28. K Havenga DC Cobben WJ Oyen S Nienhuijs HJ Hoekstra TJ Ruers 2003 Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma Eur J Surg Oncol 29 8 662 664
29. DJ Macfarlane V Sondak T Johnson RL Wahl 1998 Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma J Clin Oncol 16 5 1770 1776
30. JD Wagner D Schauwecker D Davidson JJ Coleman 3rd S Saxman G Hutchins 1999 Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy J Clin Oncol 17 5 1508 1515